Associate Director/Director
Lakefront Biotherapeutics
Associate Director/Director
Lakefront Biotherapeutics
Biopharmaceuticals pursuing immunology and oncology assets
ABOUT LAKEFRONT BIOTHERAPEUTICS
Lakefront Biotherapeutics is a global biotech with offices in Belgium, Chicago and San Francisco, focused on building a differentiated immunology and inflammation pipeline to address serious diseases with high unmet medical need. Our pipeline is anchored by T‑cell engager programs, led by a potential first‑in‑class clinical asset and complemented by an exciting preclinical portfolio in autoimmune disease.
Our lead asset is being developed for severe immune‑mediated diseases, while additional preclinical programs expand the long‑term potential of our R&D pipeline. At Lakefront, we focus on advancing programs with strong biological rationale, clear clinical proof of concept and large commercial opportunities.
Are you ready to transform lives and be part of a journey like no other? We are building a company where science, execution, and accountability matter. Rather than layers of hierarchy, we operate with small, empowered teams that work hands‑on across development stages to move programs forward efficiently and thoughtfully.
We are looking for people who want to contribute directly, who are motivated by solving real problems, collaborating across disciplines, and taking ownership from idea to impact. At Lakefront, every role plays a part in shaping the future of medicines that have the potential to make a meaningful difference for patients.
If you are driven to improve the lives of patients, energized by execution, and excited to help build a growing company with a strong balance sheet, we look forward to meeting you.
The Role
Lakefront Biotherapeutics is seeking an experienced and highly motivated Associate Director / Director, Search & Evaluation to identify, evaluate, and advance external business development opportunities that strengthen Lakefront Biotherapeutics’ R&D pipeline and support long-term strategy. This role requires strong scientific judgment, drug development expertise, and strategic thinking to evaluate licensing, collaboration, and M&A opportunities. The Associate Director / Director will partner cross-functionally with Transactions, Alliance Management, Corporate Strategy, Commercial Assessment, Clinical Development, Research, Finance, Legal, and other key business functions.
What You'll Do
What You Bring
Key Attributes:
Base compensation for this position ranges from $180,000 - 250,000. Actual base compensation will be determined based on a variety of factors including experience, qualifications, job-related knowledge, demonstrated skills and geographic location. The company reserves the right to modify base salary ranges at any time. In addition, this position is eligible for participation in Lakefront Biotherapeutics’ performance bonus plan. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support important moments in life.
At Lakefront Biotherapeutics, we are committed to attracting individuals who bring strong expertise, integrity, and a collaborative mindset. We value people who take ownership, work effectively across teams, and want to contribute to meaningful progress.
You will join a highly motivated and supportive team working together to advance our pipeline and strengthen how we operate. As we continue to build and grow, we offer an environment where individuals can develop, take on responsibility, and make a tangible impact.
Lakefront Biotherapeutics is dedicated to ensuring equal employment opportunities. Our hiring decisions are based on merit, considering qualifications, skills, performance, and achievements. We strictly prohibit discrimination against any employee or job applicant based on personal characteristics that are unrelated to their job.
Biopharmaceuticals pursuing immunology and oncology assets
Lakefront Biotherapeutics is a European biopharmaceutical company that now concentrates on business development by acquiring and partnering with clinical-stage assets in immunology and oncology. It operates by using its cash reserves to pursue strategic transactions, including targeted acquisitions and collaborations, to advance external research with human proof-of-concept data and bring candidates toward development and potential commercialization. The company differentiates itself by divesting non-core assets (like Jyseleca) and winding down its cell therapy activities to focus resources on building a diversified portfolio through partnerships, licenses, and Investigator Sponsored Research programs. Its goal is to create value for patients and shareholders by accelerating the development of promising immunology and oncology therapies through external assets and strategic collaborations, including an ongoing collaboration with its major shareholder Gilead on a T-cell engager program.
Explore more opportunities at Lakefront Biotherapeutics